Suppliers / Zhejiang Dayang Biotech Group

Zhejiang Dayang Biotech Group

China Updated 9 July 2026

Zhejiang Dayang Biotech Group is a contract manufacturer based in China. It appears in 1 regulatory filing across 1 regulator, without an active US DMF or CEP on file. Its most recent recorded inspection, by US FDA, closed on 10 July 2015 as VAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 10 July 2015 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3009493201

Filings and GMP by regulator

Regulator Filings GMP certificates
BRELA (TZ) 1 None

Questions about Zhejiang Dayang Biotech Group

Does Zhejiang Dayang Biotech Group hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Zhejiang Dayang Biotech Group. It does have 1 filing with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Zhejiang Dayang Biotech Group FDA-registered?
One site operated by Zhejiang Dayang Biotech Group carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Zhejiang Dayang Biotech Group's last inspection go?
The most recent inspection on record closed on 10 July 2015 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Zhejiang Dayang Biotech Group manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
Where does Zhejiang Dayang Biotech Group file?
Filings are on record with BRELA (TZ), 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Dayang Biotech Group comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 10 July 2015.

Comparable suppliers

Astrazeneca Pharmaceutical also in China Changzhou Syntheall Pharmaceutical also in China Changzhou Yinsheng Pharmaceutical also in China Chengdu Shuode Pharmaceutical also in China Chia Tai Tianqing Pharmaceutical Group also in China

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability